HighVista Strategies »

Gitlab shares owned by HighVista Strategies

Quarter-by-quarter ownership of Gitlab (GTLB) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in Gitlab

Tip: Access up to 7 years of quarterly data

All positions including Gitlab held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gitlab by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-12-31 $725k 19k 37.53

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Structure Therapeutics Sponsored Ads (GPCR)
Cogent Biosciences (COGT)
Miragen Therapeutics (VRDN)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Praxis Precision Medicines I Com New (PRAX)
Nuvalent Inc-a (NUVL)
Cytokinetics Com New (CYTK)
Terns Pharmaceuticals (TERN)
Maze Therapeatics (MAZE)
Insmed Com Par $.01 (INSM)
Apogee Therapeutics (APGE)
Protagonist Therapeutics (PTGX)
Soleno Therapeutics (SLNO)

View all positions for HighVista Strategies

Top funds holding Gitlab

Vanguard Group
Vanguard Portfolio Management
AQR Capital Management
BlackRock
Eminence Capital
PRIMECAP Management Company
Vanguard Capital Management
Slate Path Capital
Susquehanna International
Jane Street
HMI Capital
Impactive Capital
Squarepoint Ops
Champlain Investment Partners
Two Sigma Investments

View all funds holding Gitlab